|
AU4815197A
(en)
|
1996-10-09 |
1998-05-05 |
Pharmasset, Ltd. |
Tetraphosphonate bicyclic trisanhydrides
|
|
US6348589B1
(en)
*
|
1997-02-06 |
2002-02-19 |
Inspire Pharmaceuticals, Inc. |
Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
|
|
US7223744B2
(en)
|
1997-02-10 |
2007-05-29 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
|
|
US20040181078A1
(en)
*
|
1997-10-10 |
2004-09-16 |
Pharmasset, Ltd. |
Tetraphosphonate bicyclic trisanhydrides
|
|
EP1259520B1
(en)
*
|
1999-12-17 |
2006-05-24 |
Ariad Pharmaceuticals, Inc. |
Novel purines
|
|
US7115589B2
(en)
|
1999-12-17 |
2006-10-03 |
Ariad Pharmaceuticals, Inc. |
Purine derivatives
|
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
|
US6875751B2
(en)
|
2000-06-15 |
2005-04-05 |
Idenix Pharmaceuticals, Inc. |
3′-prodrugs of 2′-deoxy-β-L-nucleosides
|
|
US6555675B2
(en)
|
2000-08-21 |
2003-04-29 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
|
|
US6867199B2
(en)
|
2000-08-21 |
2005-03-15 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapeutic use
|
|
EP1366055A2
(en)
*
|
2000-12-15 |
2003-12-03 |
Pharmasset Limited |
Antiviral agents for treatment of flaviviridae infections
|
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
WO2004096285A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
WO2004096234A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
PL1628685T3
(pl)
|
2003-04-25 |
2011-05-31 |
Gilead Sciences Inc |
Przeciwwirusowe analogi fosfonianowe
|
|
CA2734052A1
(en)
|
2003-05-30 |
2005-01-13 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
|
WO2005044308A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
WO2005044279A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Purine nucleoside phosphonate conjugates
|
|
EP1706405B1
(en)
|
2003-12-22 |
2009-03-04 |
Gilead Sciences, Inc. |
4'-substituted carbovir- and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
|
|
DE10361932A1
(de)
*
|
2003-12-30 |
2005-07-28 |
Celanese Ventures Gmbh |
Protonenleitende Membran und deren Verwendung
|
|
DE10361832A1
(de)
*
|
2003-12-30 |
2005-07-28 |
Celanese Ventures Gmbh |
Protonenleitende Membran und deren Verwendung
|
|
US8318701B2
(en)
|
2004-07-27 |
2012-11-27 |
Gilead Sciences, Inc. |
Phosphonate analogs of HIV inhibitor compounds
|
|
WO2007039635A2
(en)
*
|
2005-10-06 |
2007-04-12 |
Innate Pharma |
Phosphoantigen salts of organic bases and methods for their crystallization
|
|
US20090111774A1
(en)
*
|
2007-06-01 |
2009-04-30 |
Luitpold Pharmaceuticals, Inc. |
Pmea lipid conjugates
|
|
AU2009214591B2
(en)
*
|
2008-02-15 |
2013-11-14 |
Microdose Therapeutx, Inc. |
Methods of making nucleoside tetraphosphate analogs
|
|
EA018308B1
(ru)
|
2008-07-08 |
2013-07-30 |
Джилид Сайэнс, Инк. |
Соли соединений ингибиторов вич
|
|
WO2010048585A2
(en)
|
2008-10-24 |
2010-04-29 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
|
JP6005628B2
(ja)
|
2010-04-28 |
2016-10-12 |
アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
修飾ヌクレオシド、その類似体、およびこれらから調製されるオリゴマー化合物
|
|
WO2011139695A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Modified 5' diphosphate nucleosides and oligomeric compounds prepared therefrom
|
|
EP2625186B1
(en)
|
2010-04-28 |
2016-07-27 |
Ionis Pharmaceuticals, Inc. |
5' modified nucleosides and oligomeric compounds prepared therefrom
|
|
BR112015021222A2
(pt)
*
|
2013-03-13 |
2017-07-18 |
Dana Farber Cancer Inst Inc |
inibidores de ras e usos dos mesmos
|
|
HUE063388T2
(hu)
|
2016-01-08 |
2024-01-28 |
Arcus Biosciences Inc |
Ekto-5'-nukleotidáz modulátorok és ezek alkalmazása
|
|
EP3541396A4
(en)
|
2016-11-18 |
2020-07-22 |
Arcus Biosciences, Inc. |
CD73-MEDIATED IMMUNOSUPPRESSION INHIBITORS
|
|
ES2892402T3
(es)
|
2017-08-01 |
2022-02-04 |
Gilead Sciences Inc |
Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
|
|
WO2020210970A1
(en)
*
|
2019-04-16 |
2020-10-22 |
Bioardis Llc |
Imidazotriazine derivatives as cd73 inhibitors
|
|
US11633416B1
(en)
|
2020-03-06 |
2023-04-25 |
Arcus Biosciences, Inc. |
Oral formulations of CD73 compounds
|